Related Experiment Video
Updated: Jun 18, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Functional magnetic stimulation in constipation associated with Parkinson's disease
Cheng-Ming Chiu1, Chih-Pin Wang, Wen-Hsu Sung
1Department of Physical Medicine and Rehabilitation, Far Eastern Memorial Hospital, Taipei, Taiwan, ROC.
Journal of Rehabilitation Medicine
|November 7, 2009
Summary
Functional magnetic stimulation significantly improved colonic transit time and recto-anal function in Parkinson's disease patients. These positive effects on colonic motility and anorectal angle were sustained at 3-month follow-up.
Area of Science:
- Neurogastroenterology
- Gastrointestinal Motility Disorders
- Neurological Rehabilitation
Background:
- Parkinson's disease frequently causes gastrointestinal dysfunction, particularly constipation, impacting quality of life.
- Colonic transit time and anorectal manometry are key indicators of lower gastrointestinal function.
- Current treatments for constipation in Parkinson's disease have limitations.
Purpose of the Study:
- To evaluate the efficacy of functional magnetic stimulation (FMS) on colonic transit time in Parkinson's disease (PD) patients.
- To assess changes in recto-anal function and defecation dynamics following FMS.
- To determine the durability of FMS effects through a 3-month follow-up.
Main Methods:
- A prospective, before-after trial involving 16 Parkinson's disease patients.
- A 3-week protocol of twice-daily 20-minute functional magnetic stimulation sessions.
- Measurements included colonic transit time, symptom questionnaires, and defecography before and after intervention.
Main Results:
- Statistically significant reductions in colonic transit time and constipation symptom scores were observed post-intervention.
- Significant improvements in anorectal angle dynamics during rest and evacuation were noted.
- Pelvic floor descent also showed significant changes, indicating improved defecation mechanics.
Conclusions:
- Functional magnetic stimulation effectively enhances colonic motility and improves anorectal angle in Parkinson's disease patients.
- The observed therapeutic benefits demonstrate sustained efficacy over a 3-month period.
- FMS presents a promising non-invasive therapeutic option for managing constipation and defecation disorders in Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...